Commentary: RCT of optimal dose methylphenidate in children and adolescents with severe ADHD and ID--a reply to Arnold (2013).

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Child Psychology and Psychiatry and Allied Disciplines

• Publication date

  2013-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/jcpp.12098PMID 23692251
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.

  2013cited by this paper
• Commentary: Filling out the evidence base for treatment of attention-deficit hyperactivity disorder symptoms in children with intellectual and developmental disability: conclusions for clinicians--a response to Simonoff et al. (2013).

  2013cited by this paper
• Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP).

  2006cited by this paper
• Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

  2005cited by this paper
• Refining the diagnoses of inattention and overactivity syndromes: A reanalysis of the Multimodal Treatment study of attention deficit hyperactivity disorder (ADHD) based on ICD-10 criteria for hyperkinetic disorder

  2005cited by this paper
• Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.

  2000cited by this paper

• Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors

  2022cites this paper
• Crossing the divide: a longitudinal study of effective treatments for people with autism and attention deficit hyperactivity disorder across the lifespan

  2018cites this paper